None of the 29 investors followed here reported a position in NESN.SW in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a NESN.SW trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for NESN.SW.
Nestlé S.A., together with its subsidiaries, manufactures and distributes food and beverage, and nutritional science products in the United States, Brazil, Mexico, Greater China, the Philippines, India, the United Kingdom, France, Germany, Switzerland, and internationally. The company offers cereals, chocolate and confectionery, coffee, culinary, chilled and frozen food, dairy, drinks, food service, ice cream, nutrition and health, petcare, water, plant-based portfolio, and recipe products. It sells its products under the Nesquik Cereal, Fitness, Cheerios, Lion Cereals, Cini Minis, KitKat Cereal, Chocapic, Koko Krunch, Shreddies, Shredded Wheat Original, Corn Flakes, Trix Cereal, Aero, Baci Perugina, KitKat, Milkybar, Smarties, Cailler, Quality Street, Garoto, Nestlé Toll House, Munch, Damak, Hsu Fu Chi, Sahne Nuss, Nestlé Sustainably Sourced Cocoa, Blue Bottle Coffee, Nescafé, Nescafé Dolce Gusto, Nespresso, Starbucks Coffee At Home, DiGiorno, Garden Gourmet, Maggi, Thomy, Stouffer's, Hot Pockets, Lean Cuisine, Life Cuisine, Buitoni, Nestlé carnation, Nestlé Coffee Mate, and Nestea brands. The company also offers its products under the Roastelier by Nescafé, Plant-based and so good!, Milo, Chef, Maggi Professional, La Lechera, Minor's, Antica Gelateria Del Corso, Drumstick, Extrême, Häagen-Dazs, Maxibon, Mövenpick, Nancare, Gerber, Cerelac, Nestum, Alfaré HMO, Athéra HMO, Alfamino HMO, Bear Brand, Nido, Orgain, Nestlé Vital, Garden of Life, Pure Encapsulations, Solgar, Compleat, Impact, Peptamen, Vitaflo, Resource, Cat Chow, Dentalife, Dog Chow, Fancy Feast, Felix, Friskies, Gourmet, Purina, Purina ONE, Purina Pro Plan, Purina Pro Plan Veterinary Diets, Acqua Panna, Nestlé Pure Life, Perrier, S.Pellegrino, Sanpellegrino, Buxton, Erikli, Levissima, Vittel, Contrex, HENNIEZ, Hépar, La Vie, Naleczowianka, and Essentia brands. The company was founded in 1866 and is headquartered in Vevey, Switzerland. Aimmune Therapeutics, Inc. operates as a subsidiary of Nestlé S.A.
Buy / hold / sell counts
No recent headlines.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.7 | 14.4 | -6.6 | 0.8 | 0.5 | 4.6 | -2.5 | -2.7 | -3.6 | 2.3 | −1.2% | ||
| 2025 | 3.5 | 12.4 | 2.5 | -1.8 | -0.0 | -10.1 | -9.8 | 6.0 | -3.1 | 5.2 | 3.8 | -1.4 | +5.2% |
| 2024 | 1.1 | -6.9 | 4.3 | -3.7 | 3.6 | -4.0 | -2.8 | 2.1 | -6.7 | -4.0 | -6.3 | -2.1 | −23.2% |
| 2023 | 4.1 | -4.8 | 5.1 | 2.7 | -5.8 | -0.3 | -0.7 | -0.4 | -2.5 | -5.5 | 1.3 | -1.9 | −9.0% |
| 2022 | -6.6 | 0.6 | 0.4 | 4.8 | -7.1 | -4.8 | 4.5 | -1.6 | -6.5 | 1.8 | 3.0 | -4.6 | −15.9% |
| 2021 | -4.0 | -5.0 | 10.9 | 3.4 | 1.7 | 4.1 | -0.4 | 0.8 | -2.6 | 7.2 | -2.3 | 8.0 | +22.2% |
| 2020 | 1.5 | -7.1 | 0.6 | 2.5 | 1.9 | 0.8 | 3.2 | 0.4 | 0.7 | -5.7 | -1.9 | 3.0 | −0.5% |
| 2019 | 8.3 | 4.5 | 5.1 | 3.2 | 1.5 | 1.5 | 4.6 | 5.0 | -2.5 | -2.7 | -1.3 | 0.8 | +31.3% |
| 2018 | -4.0 | -6.4 | 0.5 | 1.8 | -3.4 | 3.4 | 4.9 | 0.8 | 0.5 | 4.0 | 0.0 | -6.3 | −4.8% |
| 2017 | -1.0 | 2.7 | 3.5 | -0.3 | 7.8 | 1.0 | -2.1 | -0.4 | -0.3 | 3.5 | 0.4 | -0.5 | +14.7% |
| 2016 | 0.9 | -6.8 | 2.5 | -0.5 | 2.7 | 2.4 | 3.4 | 0.8 | -2.2 | -6.3 | -4.7 | 6.8 | −2.0% |
| 2015 | -3.4 | 5.6 | -1.3 | -0.7 | 0.0 | -7.4 | 8.4 | -2.6 | 2.7 | 3.2 | 1.0 | -2.4 | +2.2% |
| 2014 | 0.8 | 1.2 | -0.1 | 2.1 | 3.4 | -2.2 | -1.7 | 5.5 | -1.4 | 0.2 | 3.1 | 0.6 | +11.7% |
| 2013 | 7.2 | 2.5 | 4.8 | -3.3 | -4.4 | -2.4 | 1.2 | -2.6 | 3.6 | 3.6 | 1.1 | -1.4 | +9.6% |
| 2012 | -2.3 | 4.8 | 2.7 | -2.1 | -1.0 | 2.7 | 6.2 | -1.2 | -0.1 | -0.3 | 2.6 | -1.7 | +10.4% |
| 2011 | -6.8 | 3.0 | 0.1 | 2.0 | 2.0 | -4.6 | -3.8 | -0.7 | 0.4 | 1.6 | 0.5 | 5.6 | −1.4% |
| 2010 | 0.6 | 5.8 | 1.0 | -2.1 | -0.9 | -0.4 | -1.3 | 2.1 | -0.5 | 3.0 | 1.2 | 0.4 | +9.1% |
| 2009 | -3.4 | -4.6 | 0.4 | -2.9 | 3.6 | 5.7 | 7.5 | 0.0 | 0.4 | 8.3 | -0.7 | 5.7 | +20.7% |
| 2008 | -7.1 | 3.4 | -0.7 | 0.2 | 3.1 | -9.9 | -0.2 | 5.5 | -0.8 | -6.6 | -2.4 | -5.3 | −20.0% |
| 2007 | 5.4 | -0.5 | 4.2 | 1.4 | -0.6 | -2.3 | -0.2 | 13.0 | -0.5 | 2.2 | 1.6 | -4.2 | +20.1% |